Cytoreductive surgery is feasible in patients with limited regional platinum-resistant recurrent ovarian cancer.

Authors:
Zou R; Jiang Q; Luo X; Chen M; Yuan L and 1 more

Journal:
World J Surg Oncol

Publication Year: 2023

DOI:
10.1186/s12957-023-03230-3

PMCID:
PMC10688147

PMID:
38037085

Journal Information

Full Title: World J Surg Oncol

Abbreviation: World J Surg Oncol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: General Surgery

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Ethics approval and consent to participateThe study protocol was approved by the Ethics Committee of the Obstetrics and Gynecology Hospital of Fudan University (ChiCTR2100048956). Consent for publicationVerbal informed consent was obtained from the patients for their anonymized information to be published in this article. Competing interestsThe authors declare no competing interests. Competing interests The authors declare no competing interests."

Evidence found in paper:

"Funding This work was supported by the National Natural Science Foundation of China (82002750 to Mo Chen), the Shanghai Municipal Health and Family Planning Commission (20184Y0254 to Mo Chen) and the Sponsored by Shanghai Pujiang Programme (23PJD009 to Mo Chen)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025